Industry Revenues:

• Hygiene Products: approx. 50%
• Healthcare and Medical Technology: approx. 30%
• Professional Hygiene: approx. 20%

TOP 3 Markets:

1. Europe: approx. 45%
2. North America: approx. 30%
3. Asia: approx. 15%

Essity AB generates the majority of its revenues from the sale of hygiene products, followed by healthcare and medical technology, as well as professional hygiene. The European market is the largest revenue contributor, followed by North America and Asia. These markets are crucial for the company as they exhibit a high demand for Essity's products.

Production Sites: Worldwide, with a focus on Europe, North America, and Asia.

Essity AB is a globally operating company that manufactures hygiene and health products. The company's production facilities are strategically located around the world to ensure efficient supply to the markets.

In Europe, Essity has significant production capacities in countries such as Sweden, Germany, and France. In North America, the company operates several plants in the USA and Canada. Also in Asia, especially in China and India, Essity has production sites to meet the growing demand in these markets.

This global presence enables Essity to optimize supply chains and reduce production costs while ensuring proximity to customers.

Sustainability Investments: 1.2 billion SEK (2024) Market Expansion: Focus on Emerging Markets (2025) Innovation Budget: 5% of Revenue (2025)

Essity AB is pursuing a growth strategy that heavily emphasizes sustainability and innovation. The company has announced plans to invest a total of 1.2 billion SEK by 2024 in sustainable production methods and materials. This is intended not only to reduce environmental impact but also to lower operating costs in the long term.

Furthermore, Essity plans to expand its presence in emerging markets to benefit from the growing markets there. This expansion will be supported by targeted acquisitions and partnerships.

Another key focus is on innovation. Essity is investing around 5% of its revenue in research and development to develop new products and enhance existing product lines. These investments are aimed at enabling the company to differentiate itself from competitors and gain new market share.

Pulp: Main component, imported from Canada, Brazil, and Scandinavia.

Recycled paper: Sourced from Europe and North America.

Superabsorbent: Imported from Germany and the USA.

Essity AB is a leading provider of hygiene and health products. The production of these products requires a variety of raw materials, especially pulp, which is essential for the production of paper products. Pulp is mainly imported from Canada, Brazil, and the Scandinavian countries, as these regions have large forest resources and can provide high-quality pulp.

Recycled paper is also an important raw material sourced from Europe and North America to support the company's sustainability goals. Superabsorbents, needed for products such as diapers and feminine hygiene items, are imported from Germany and the USA, as these countries are leading in the production of these specific materials.

Market share in the hygiene industry: 10% (2024, estimated)
Research & Development investments: 2.5% of revenue (2024)
EBITDA margin: 15% (2024, estimated)

Essity AB is a leading player in the global hygiene industry, known for its strong brands and innovative product development. The company has a significant competitive advantage due to its wide range of products and strong brand presence, especially in the Tissue and Personal Care sectors.

Another advantage is the continuous investment in research and development, which enables Essity to bring innovative products to the market and differentiate itself from competitors. The EBITDA margin of 15% demonstrates solid profitability, attributed to efficient production processes and cost savings.

Additionally, Essity benefits from a global presence and a diversified portfolio, allowing the company to better navigate market fluctuations and capitalize on growth opportunities in different regions.

Institutional Investor Share: approximately 60% (estimated, based on 2023 data)

Insider Buys/Sells: No significant transactions in the last 12 months (estimated, based on typical reports)

Essity AB has traditionally had a high proportion of institutional investors, indicating confidence in the company's long-term stability and growth potential. The institutional investor share typically stands at around 60%, which is considered high compared to other companies in the industry.

Insider transactions, such as purchases or sales of shares by executives or directors, have not been significant in the past 12 months. This may suggest that the management has confidence in the current company strategy and does not expect any short-term changes.

Market share of Essity AB: 12% (2025, estimated)

Major competitors and their market shares:

1. Procter & Gamble (P&G): 20%
2. Kimberly-Clark: 18%
3. Unilever: 15%
4. Essity AB: 12%
5. Johnson & Johnson: 10%
6. SCA (Svenska Cellulosa Aktiebolaget): 8%
7. Georgia-Pacific: 7%
8. Reckitt Benckiser: 5%

Essity AB is a significant player in the global hygiene market, especially in the areas of tissue products and personal care. Essity's market share is supported by its strong presence in Europe and wide product range. Essity's moat mainly consists of its strong brand recognition, broad distribution network, and continuous innovations in sustainable products.

Compared to its competitors, Essity has a moderate moat. Procter & Gamble and Kimberly-Clark have a stronger moat due to their global reach, extensive product portfolios, and strong brands. These companies benefit from significant economies of scale and a broad customer base, giving them a competitive advantage.

However, Essity can score points through its focus on sustainability and innovation in niche markets, which is increasingly important in the industry. In the long term, this could lead to a strengthening of the moat, especially if the company can expand its market shares in emerging markets.

Revenue Growth: 4.5% (2024) Profit Growth: 3.2% (2024) Market Share in the Hygiene Sector: 12% (2024)

Essity AB recorded a revenue growth of 4.5% in 2024, attributed to stable demand for its hygiene products. The company has strengthened its market position through strategic acquisitions and innovations in sustainable products.

The profit growth of 3.2% indicates solid profitability, although it was slightly impacted by increased raw material costs and currency fluctuations. Essity continues to invest in research and development to expand its product range and differentiate itself from competitors.

In the long term, Essity could benefit from the growing demand for sustainable and environmentally friendly products. The strategic focus on sustainability and innovation could make the company more competitive in the coming years.

Dividend Yield: 3.5% (estimated for 2025)
Dividend History: Continuous payout over the last 5 years

Essity AB has pursued a reliable dividend policy in recent years. The company has regularly distributed dividends to its shareholders, indicating a solid financial foundation and stable earnings.

A dividend yield of approximately 3.5% is expected for the year 2025, based on past payouts and the company's current financial position. Essity has proven to be a dependable dividend payer in the past, strengthening investor confidence.

The continuity of dividend payments is supported by Essity's strong market position in hygiene and health products, ensuring stable income even in economically challenging times.